Veterinary Renal Disease Global Market Report 2026
상품코드:1938752
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수의 신장질환 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 165억 9,000만 달러에서 2026년에는 177억 3,000만 달러로, CAGR 6.9%로 성장할 것으로 예상됩니다. 지난 몇 년간 성장 요인으로는 반려동물의 고령화, 동물의 신장 질환 진단 지연, 고급 신장 치료법의 제한된 가용성, 탈수 및 감염 발생률 증가, 대증요법에 대한 의존도 등을 꼽을 수 있습니다.
수의 신장질환 시장 규모는 향후 몇 년간 견조한 성장이 전망됩니다. 2030년에는 224억 2,000만 달러에 달하고, CAGR은 6.0%가 될 전망입니다. 예측 기간의 성장 요인으로는 신장 진단 및 영상 진단 기술의 발전, 예방적 스크리닝 프로그램 도입 확대, 표적 신장 치료제 개발, 수의학 투석 서비스 보급 확대, 만성 신장 질환 관리에 대한 인식 개선 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 반려동물의 만성 신장 질환 유병률 증가, 조기 진단 및 정기적인 신장 검진에 대한 관심 증가, 장기 신장 관리 요법의 도입 확대, 전문 신장 치료 및 투석 서비스 확대, 신장 건강을 위한 영양 관리 및 지지요법의 중요성 등을 들 수 있습니다.
반려동물 사육 수의 증가는 향후 몇 년 동안 수의학 신장 질환 시장의 성장을 견인할 것으로 예상됩니다. 수의신장질환이란 동물의 신장기능에 영향을 미쳐 다뇨, 빈뇨, 식욕감퇴, 체중감소 등의 증상을 유발할 수 있는 병태를 말합니다. 수의학적 신장 질환의 유병률 증가는 반려동물의 수명 연장, 환경 독소 노출, 식습관의 영향, 유전적 소인 등의 요인과 관련이 있습니다. 수의학적 신장 질환의 치료 접근법에는 일반적으로 증상 관리, 질병 진행 지연, 반려동물의 삶의 질 향상을 위한 식이요법, 약물 치료, 수액 요법 등이 포함됩니다. 예를 들어, 캐나다에 본사를 둔 업계 단체인 캐나다 동물 건강 연구소(Canadian Animal Health Institute)에 따르면, 2025년 4월 기준, 2024년 캐나다의 개 사육 수는 약 720만 마리, 고양이는 820만 마리로 추정되며, 반려동물은 캐나다 가구의 절반 이상에서 필수적인 존재로 자리 잡았습니다.에서 반려동물은 필수적인 존재가 되었습니다. 따라서 반려동물 사육 수의 증가가 수의학 신장질환 시장 성장에 기여하고 있습니다.
수의신장질환 시장에서 사업을 전개하고 있는 주요 기업들은 임상 증상이 나타나기 전 단계부터 신장질환을 확인할 수 있는 신규 진단 검사 개발 등 치료 및 진단기술의 발전에 주력하고 있습니다. 이러한 진단 검사는 신장의 구조와 기능의 미세한 변화를 감지하도록 설계되어 조기 개입을 가능하게 하고, 신장 질환의 진행 단계로의 전환을 예방하는 데 기여합니다. 예를 들어, 2023년 6월, 미국에 본사를 둔 수의학 제품 및 서비스 개발 및 제조 회사인 IDEXX Laboratories Inc.는 고양이와 개의 신장 손상을 감지하는 최초의 수의학 진단 검사를 발표했습니다. IDEXX Cystatin B Test로 알려진 이 혁신적인 검사는 수의사가 신장 기능에 뚜렷한 변화가 발생하기 전에 신장 손상을 식별하여 환자의 예후를 개선하는 데 도움을 줄 수 있습니다. IDEXX 시스타틴 B 검사는 신장 건강 검사 패널에 통합되어 연간 약 200만 건의 환자 진료에서 귀중한 정보를 제공할 것으로 기대되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Veterinary renal disease encompasses a range of conditions that affect the kidneys of animals, resulting in impaired kidney function. This disruption affects the kidneys' ability to filter waste, balance fluids, and produce certain hormones, leading to various health issues.
The main types of veterinary renal disease involve diagnosis and treatment. Diagnosis involves reaching a conclusion through medical evaluation, identifying specific conditions or diseases affecting an individual animal's health. The types of animals affected include canine, feline, bovine, equine, and others, with indications such as renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, among others. Treatment can be administered via injectable or oral routes and products are distributed through pharmacies, pet specialty stores, e-commerce platforms, and other channels.
Tariffs have affected the veterinary renal disease market by increasing costs of imported diagnostic equipment, medications, and dialysis systems, influencing treatment affordability and access. Regions such as north america and europe are most impacted due to dependence on specialized imported renal care technologies. Segments including diagnostic imaging, dialysis, and advanced medications have faced cost pressures, while tariffs have encouraged local manufacturing, regional sourcing, and development of cost-effective renal treatment solutions. Overall, tariffs have driven supply chain diversification and localized production efforts.
The veterinary renal disease market research report is one of a series of new reports from The Business Research Company that provides veterinary renal disease market statistics, including veterinary renal disease industry global market size, regional shares, competitors with a veterinary renal disease market share, detailed veterinary renal disease market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary renal disease industry. This veterinary renal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary renal disease market size has grown strongly in recent years. It will grow from $16.59 billion in 2025 to $17.73 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to aging pet population, late diagnosis of renal disorders in animals, limited availability of advanced renal treatments, increasing incidence of dehydration and infections, reliance on symptomatic treatment approaches.
The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $22.42 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to advancements in renal diagnostics and imaging, rising adoption of preventive screening programs, development of targeted renal medications, increasing availability of veterinary dialysis services, growing awareness of chronic kidney disease management. Major trends in the forecast period include rising prevalence of chronic kidney disease in companion animals, increasing focus on early diagnosis and routine renal screening, growing adoption of long-term renal management therapies, expansion of specialized renal treatment and dialysis services, emphasis on nutritional and supportive care for renal health.
The rise in pet ownership is expected to drive the growth of the veterinary renal disease market in the coming years. Veterinary renal disease includes conditions that affect kidney function in animals and can lead to symptoms such as increased thirst, frequent urination, reduced appetite, and weight loss. The growing prevalence of veterinary renal disease is associated with factors such as longer pet lifespans, exposure to environmental toxins, dietary influences, and genetic predispositions. Treatment approaches for veterinary renal disease typically include dietary modifications, medications, and fluid therapy to manage symptoms, slow disease progression, and enhance pets' quality of life. For example, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, Canada was home to an estimated 7.2 million dogs and 8.2 million cats in 2024, with pets forming an essential part of more than half of Canadian households. Therefore, increasing pet ownership is contributing to the growth of the veterinary renal disease market.
Major companies operating in the veterinary renal disease market are focusing on advancing treatment and diagnostic technologies, including the development of novel diagnostic tests capable of identifying kidney injury even before clinical symptoms become evident. These diagnostic tests are designed to detect subtle changes in renal structure or function, enabling earlier intervention and helping to prevent progression to more advanced stages of kidney disease. For instance, in June 2023, IDEXX Laboratories Inc., a U.S.-based developer and manufacturer of veterinary products and services, launched the first veterinary diagnostic test for detecting kidney injury in cats and dogs. Known as the IDEXX Cystatin B Test, this innovation helps veterinarians identify kidney injury before noticeable changes in kidney function occur, supporting improved patient outcomes. The IDEXX Cystatin B Test is being incorporated into renal health test panels and is expected to provide valuable insights during approximately two million patient visits each year.
In June 2023, Mars Incorporated, a U.S.-based diversified food and pet care technology company, acquired Heska Corporation for around $1.3 billion. Through this acquisition, Mars aimed to strengthen and expand its pet health and veterinary diagnostics portfolio by increasing access to advanced diagnostic technologies, accelerating research and development efforts, and supporting a broader global network of veterinary professionals and pets. Heska Corporation is a U.S.-based healthcare technology company specializing in advanced veterinary diagnostic and specialty products and solutions.
Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestle Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Sante Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Veterinary Transplant Services Inc., Kibow Biotech Inc.
North America was the largest region in the veterinary renal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary renal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary renal disease market consists of revenues earned by entities by providing services such as laboratory testing, imaging services, and fluid therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary renal disease market also includes sales of angiotensin receptor blockers, phosphate binders, omega-3 fatty acids, and antioxidants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Renal Disease Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary renal disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary renal disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary renal disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Diagnosis; Treatment
2) By Animal Type: Canine; Feline; Bovine; Equine; Other Animal Types
3) By Indication: Renal Failure; Chronic Kidney Disease (Ckd); Renal Cystitis; Kidney Stones; Nephritis; Other Indications
4) By Route Of Administration: Injectable; Oral
5) By Distribution Channel: Pharmacies; Pet Specialty Stores; E-Commerce; Other Distribution Channels
Subsegments:
1) By Diagnosis: Blood Tests; Urine Tests; Imaging; Biopsy
2) By Treatment: Medications; Dialysis; Kidney Transplantation; Fluid Therapy
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
4.2.1 Rising Prevalence Of Chronic Kidney Disease In Companion Animals
4.2.2 Increasing Focus On Early Diagnosis And Routine Renal Screening
4.2.3 Growing Adoption Of Long-Term Renal Management Therapies
4.2.4 Expansion Of Specialized Renal Treatment And Dialysis Services
4.2.5 Emphasis On Nutritional And Supportive Care For Renal Health
5. Veterinary Renal Disease Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Veterinary Clinics
5.3 Specialty Veterinary Care Centers
5.4 Animal Diagnostic Laboratories
5.5 Research And Academic Institutions
6. Veterinary Renal Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Veterinary Renal Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Veterinary Renal Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Veterinary Renal Disease Market Size, Comparisons And Growth Rate Analysis
7.3. Global Veterinary Renal Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Veterinary Renal Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Veterinary Renal Disease Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Veterinary Renal Disease Market Segmentation
9.1. Global Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Diagnosis, Treatment
9.2. Global Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Canine, Feline, Bovine, Equine, Other Animal Types
9.3. Global Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Veterinary Renal Disease Market
12.1. China Veterinary Renal Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Veterinary Renal Disease Market
13.1. India Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Veterinary Renal Disease Market
14.1. Japan Veterinary Renal Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Veterinary Renal Disease Market
15.1. Australia Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Veterinary Renal Disease Market
16.1. Indonesia Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Veterinary Renal Disease Market
17.1. South Korea Veterinary Renal Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Veterinary Renal Disease Market
19.1. South East Asia Veterinary Renal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Veterinary Renal Disease Market
20.1. Western Europe Veterinary Renal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Veterinary Renal Disease Market
21.1. UK Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Veterinary Renal Disease Market
22.1. Germany Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Veterinary Renal Disease Market
23.1. France Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Veterinary Renal Disease Market
24.1. Italy Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Veterinary Renal Disease Market
25.1. Spain Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Veterinary Renal Disease Market
26.1. Eastern Europe Veterinary Renal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Veterinary Renal Disease Market
27.1. Russia Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Veterinary Renal Disease Market
28.1. North America Veterinary Renal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Veterinary Renal Disease Market
29.1. USA Veterinary Renal Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Veterinary Renal Disease Market
31.1. South America Veterinary Renal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Veterinary Renal Disease Market
32.1. Brazil Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Veterinary Renal Disease Market
33.1. Middle East Veterinary Renal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Veterinary Renal Disease Market
34.1. Africa Veterinary Renal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Veterinary Renal Disease Market, Segmentation By Type, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Veterinary Renal Disease Market Regulatory and Investment Landscape
36. Veterinary Renal Disease Market Competitive Landscape And Company Profiles
